Skip to main content
Screener/Healthcare/Biotechnology

RNA — Atrium Therapeutics, Inc.

NASDAQ
$13.10+0.14 (+1.04%)
Micro CapUnder $20Healthcare
$11.95
$73.06
$12.84
$13.19
EPS (TTM)$-3.38
P/E Ratio-2.80
Dividend Yield—
Market Cap$200.1M
Volume73K
Prev Close$12.96
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$859K-$48.1M$0.00100.0%-5595.9%
Q3 '25$12.5M-$174.4M$-1.27—-1398.3%
Q2 '25$3.8M-$157.3M$-1.21—-4089.3%
Q1 '25$1.6M-$115.8M$-0.90—-7360.0%
Q3 '24$2.3M-$80.4M$-0.65—-3441.7%
Q2 '24$2.0M-$70.8M$-0.65—-3461.8%
Q1 '24$3.5M-$68.9M$-0.79—-1943.4%
Q4 '23$2.2M-$60.4M$-0.80—-2756.2%
Get Your Daily Market Recap